HAMBURG, Germany & MADISON, Wis.--(BUSINESS WIRE)--Biotech and pharma labs performing endpoint polymerase chain reaction (PCR) can amplify samples in as little as 15 minutes with new Promega GoTaq® ...

DUBLIN--(BUSINESS WIRE)--The "Polymerase Chain Reaction (PCR) Technologies and Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. PCR is a powerful molecular biology ...

To permanently access this Infographic for free, fill out the short form below. There are many different polymerase chain reaction (PCR) workflows, including end-point PCR, qualitative PCR (qPCR), and ...

Pathologic complete response (pCR) is not a reliable surrogate endpoint in trials evaluating neoadjuvant therapies for early breast cancer, according to a critical analysis of the literature. This ...

A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost with an 'auto-pilot' mindset. However, how many secrets are hidden ...

You're ready to amplify some DNA - we're ready to help you get it done! If you like these videos, check out our Student Resource Center for more helpful articles and ...

The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.

In collaboration with San Diego-based Althea Technologies, Beckman Coulter http://www.beckmancoulter.com recently released the GenomeLab GeXP Genetic Analysis System ...

Axcella’s phase 2a long COVID clinical trial has missed its primary endpoint. But with the study linking the drug to improved fatigue scores versus placebo, the biotech plans to meet with regulators ...

Patients with resectable non–small cell lung cancer (NSCLC) often receive treatment before they undergo surgery. For such patients who achieve a pathologic complete response (pCR), the chances of ...

In this review, we provide a concise overview of neoadjuvant systemic therapy in early-stage HER2-positive breast cancer, with a focus on various chemotherapy backbones and de-escalation strategies.